SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech - Technical Analysis -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (382)5/13/2002 11:04:54 AM
From: Jibacoa  Read Replies (1) | Respond to of 544
 
GENXY The French genomics company, is also doing well today in spite of its increasingly reported Q losses.<g>

The institutions had been buying apparently with the lure of GENXY's obesity program and its Oligos division which is a manufacturer of oligonucleotides.<g>

Today's up-gap although not as large as the one on Wednesday, was enough to propel the price above Wednesday's H and it seems GENXY may test the resistance at 1.50 <g>

siliconinvestor.com

At any rate, the stock is up 15.65% albeit the volume remains low around 25K at present.<g>

Bernard